Ankylosis progressive homolog upregulation inhibits cell viability and mineralization during fibroblast ossification by regulating the Wnt/β‑catenin signaling pathway

He,Xindong; Dong,Yongqiang

doi:10.3892/mmr.2020.11576

Ankylosis progressive homolog upregulation inhibits cell viability and mineralization during fibroblast ossification by regulating the Wnt/β‑catenin signaling pathway

Authors:
- Xindong He
- Yongqiang Dong
View Affiliations

Affiliations: Department of Spinal Surgery, The People's Hospital of Xinchang, Xinchang, Zhejiang 312500, P.R. China
Published online on: October 11, 2020 https://doi.org/10.3892/mmr.2020.11576
Pages: 4551-4560
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ankylosis progressive homolog (ANKH) is associated with fibroblast ossification in ankylosing spondylitis (AS). As the human ANKH gene is poorly characterized relative to its murine counterpart, the aim of the present study was to examine ANKH expression in ligament tissue isolated from patients with AS and the role played by this gene in AS‑associated fibroblast ossification. Fibroblasts were isolated from ligament tissue collected from patients with AS and ligament tissue from individuals with spinal cord fractures, then cultured. Fibroblasts from patients with AS were subsequently transfected with an ANKH overexpression vector, while those collected from individuals with spinal cord fractures were transfected with small interfering RNA specific for ANKH. Cell viability, apoptosis and mineralization were analyzed using MTT assays, flow cytometry and Alizarin Red staining, respectively. Furthermore, ANKH mRNA and protein expression levels were analyzed using reverse transcription‑quantitative PCR and western blotting analysis, respectively. The expression levels of osteogenesis markers, including alkaline phosphatase, osteocalcin, Runt‑related transcription factor 2, c‑Myc, as well as the β‑catenin signaling protein, were also determined using western blotting. The results of the present study revealed that ANKH protein expression levels were downregulated in AS total ligament tissue extract, compared with spinal fracture ligament. Moreover, the fibroblasts derived from patients with AS exhibited an increased viability and reduced apoptosis rates, compared with the fibroblasts from patients with spinal fracture. Notably, ANKH overexpression inhibited viability, mineralization and ossification, increased the phosphorylation of β‑catenin and downregulated β‑catenin and c‑Myc protein expression levels in fibroblasts from patients with AS. In addition, ANKH overexpression increased the ratio of p‑β‑catenin/β‑catenin in fibroblasts from patients with AS. By contrast, ANKH silencing in fibroblasts from patients with spinal fracture resulted in the opposite effect. In conclusion, the findings of the present study suggested that ANKH may inhibit fibroblast viability, mineralization and ossification, possibly by regulating the Wnt/β‑catenin signaling pathway.

View Figures

View References

1	Smith JA: Update on ankylosing spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma Rep. 15:4892015. View Article : Google Scholar : PubMed/NCBI
2	Leone A, Marino M, Dell'Atti C, Zecchi V, Magarelli N and Colosimo C: Spinal fractures in patients with ankylosing spondylitis. Rheumatol Int. 36:1335–1346. 2016. View Article : Google Scholar : PubMed/NCBI
3	Woodward LJ and Kam PC: Ankylosing spondylitis: Recent developments and anaesthetic implications. Anaesthesia. 64:540–548. 2009. View Article : Google Scholar : PubMed/NCBI
4	Brown MA and Wordsworth BP: Genetics in ankylosing spondylitis-current state of the art and translation into clinical outcomes. Best Pract Res Clin Rheumatol. 31:763–776. 2017. View Article : Google Scholar : PubMed/NCBI
5	Hanson A and Brown MA: Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin North Am. 43:401–414. 2017. View Article : Google Scholar : PubMed/NCBI
6	Chen S, Li Y, Deng C, Li J, Wen X, Wu Z, Hu C, Zhang S, Li P, Zhang X, et al: The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis and systemic review. Rheumatol Int. 36:33–44. 2016. View Article : Google Scholar : PubMed/NCBI
7	Karami J, Mahmoudi M, Amirzargar A, Gharshasbi M, Jamshidi A, Aslani S and Nicknam MH: Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun. 18:170–175. 2017. View Article : Google Scholar : PubMed/NCBI
8	Zhang P, Li Q, Qi J, Lv Q, Zheng X, Wu X and Gu J: Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese. Int J Rheum Dis. 20:1510–1516. 2017. View Article : Google Scholar : PubMed/NCBI
9	Golder V and Schachna L: Ankylosing spondylitis: An update. Aust Fam Physician. 42:780–784. 2013.PubMed/NCBI
10	Wellcome Trust Case Control Consortium; Australo-Anglo- American Spondylitis Consortium (TASC), ; Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, et al: Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 39:1329–1337. 2007. View Article : Google Scholar : PubMed/NCBI
11	Brown MA, Kenna T and Wordsworth BP: Genetics of ankylosing spondylitis-insights into pathogenesis. Nat Rev Rheumatol. 12:81–91. 2016. View Article : Google Scholar : PubMed/NCBI
12	Ranganathan V, Gracey E, Brown MA, Inman RD and Haroon N: Pathogenesis of ankylosing spondylitis-recent advances and future directions. Nat Rev Rheumatol. 13:359–367. 2017. View Article : Google Scholar : PubMed/NCBI
13	Kirsch T, Kim HJ and Winkles JA: Progressive ankylosis gene (ank) regulates osteoblast differentiation. Cells Tissues Organs. 189:158–162. 2009. View Article : Google Scholar : PubMed/NCBI
14	Kanaujiya J, Bastow E, Luxmi R, Hao Z, Zattas D, Hochstrasser M, Reichenberger EJ and Chen IP: Rapid degradation of progressive ankylosis protein (ANKH) in craniometaphyseal dysplasia. Sci Rep. 8:157102018. View Article : Google Scholar : PubMed/NCBI
15	Mitton-Fitzgerald E, Gohr CM, Bettendorf B and Rosenthal AK: The role of ANK in calcium pyrophosphate deposition disease. Curr Rheumatol Rep. 18:252016. View Article : Google Scholar : PubMed/NCBI
16	Wang W, Xu J, Du B and Kirsch T: Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol. 25:312–323. 2005. View Article : Google Scholar : PubMed/NCBI
17	Williams CJ: The role of ANKH in pathologic mineralization of cartilage. Curr Opin Rheumatol. 28:145–151. 2016. View Article : Google Scholar : PubMed/NCBI
18	Gurley KA, Reimer RJ and Kingsley DM: Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet. 79:1017–1029. 2006. View Article : Google Scholar : PubMed/NCBI
19	Ho AM, Johnson MD and Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 289:265–270. 2000. View Article : Google Scholar : PubMed/NCBI
20	Qin X, Jiang T, Liu S, Tan J, Wu H, Zheng L and Zhao J: Effect of metformin on ossification and inflammation of fibroblasts in ankylosing spondylitis: An in vitro study. J Cell Biochem. 119:1074–1082. 2018. View Article : Google Scholar : PubMed/NCBI
21	Yu F, Cui Y, Zhou X, Zhang X and Han J: Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells. Biosci Trends. 5:46–51. 2011. View Article : Google Scholar : PubMed/NCBI
22	Rutherford RB, Moalli M, Franceschi RT, Wang D, Gu K and Krebsbach PH: Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 8:441–452. 2002. View Article : Google Scholar : PubMed/NCBI
23	Turner JD, Naylor AJ, Buckley C, Filer A and Tak PP: Fibroblasts and osteoblasts in inflammation and bone damage. Adv Exp Med Biol. 1060:37–54. 2018. View Article : Google Scholar : PubMed/NCBI
24	da Costa Fernandes CJ, do Nascimento AS, da Silva RA and Zambuzzi WF: Fibroblast contributes for osteoblastic phenotype in a MAPK-ERK and sonic hedgehog signaling-independent manner. Mol Cell Biochem. 436:111–117. 2017. View Article : Google Scholar : PubMed/NCBI
25	Zou YC, Yang XW, Yuan SG, Zhang P, Ye YL and Li YK: Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro. Connect Tissue Res. 57:200–211. 2016. View Article : Google Scholar : PubMed/NCBI
26	Zhang WH, Li XL, Guo Y and Zhang Y: Proliferation and osteogenic activity of fibroblasts induced with fibronectin. Braz J Med Biol Res. 50:e62722017. View Article : Google Scholar : PubMed/NCBI
27	Chen F, Bi D, Cao G, Cheng C, Ma S, Liu Y and Cheng K: Bone morphogenetic protein 7-transduced human dermal-derived fibroblast cells differentiate into osteoblasts and form bone in vivo. Connect Tissue Res. 59:223–232. 2018.PubMed/NCBI
28	van der Linden S, Valkenburg HA and Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI
29	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
30	Turowski P, Myles T, Hemmings BA, Fernandez A and Lamb NJ: Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55. Mol Biol Cell. 10:1997–2015. 1999. View Article : Google Scholar : PubMed/NCBI
31	Tamamura Y, Otani T, Kanatani N, Koyama E, Kitagaki J, Komori T, Yamada Y, Costantini F, Wakisaka S, Pacifici M, et al: Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J Biol Chem. 280:19185–19195. 2005. View Article : Google Scholar : PubMed/NCBI
32	Timms AE, Zhang Y, Bradbury L, Wordsworth BP and Brown MA: Investigation of the role of ANKH in ankylosing spondylitis. Arthritis Rheum. 48:2898–2902. 2003. View Article : Google Scholar : PubMed/NCBI
33	Tsui HW, Inman RD, Paterson AD, Reveille JD and Tsui FW: ANKH variants associated with ankylosing spondylitis: gender differences. Arthritis Res Ther. 7:R513–R525. 2005. View Article : Google Scholar : PubMed/NCBI
34	Gurley KA, Chen H, Guenther C, Nguyen ET, Rountree RB, Schoor M and Kingsley DM: Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res. 21:1238–1247. 2006. View Article : Google Scholar : PubMed/NCBI
35	Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, Dixey J, Gillet P, Loeuille D, McGrath R, et al: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet. 71:933–940. 2002. View Article : Google Scholar : PubMed/NCBI
36	Skubutyte R, Markova D, Freeman TA, Anderson DG, Dion AS, Williams CJ, Shapiro IM and Risbud MV: Hypoxia-inducible factor regulation of ANK expression in nucleus pulposus cells: Possible implications in controlling dystrophic mineralization in the intervertebral disc. Arthritis Rheum. 62:2707–2715. 2010. View Article : Google Scholar : PubMed/NCBI
37	Sharma U, Pal D and Prasad R: Alkaline phosphatase: An overview. Indian J Clin Biochem. 29:269–278. 2014. View Article : Google Scholar : PubMed/NCBI
38	Minashima T, Quirno M, Lee YJ and Kirsch T: The role of the progressive ankylosis protein (ANK) in adipogenic/osteogenic fate decision of precursor cells. Bone. 98:38–46. 2017. View Article : Google Scholar : PubMed/NCBI
39	Wei J and Karsenty G: An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord. 16:93–98. 2015. View Article : Google Scholar : PubMed/NCBI
40	An S, Gao Y and Ling J: Characterization of human periodontal ligament cells cultured on three-dimensional biphasic calcium phosphate scaffolds in the presence and absence of L-ascorbic acid, dexamethasone and β-glycerophosphate in vitro. Exp Ther Med. 10:1387–1393. 2015. View Article : Google Scholar : PubMed/NCBI
41	Hill TP, Später D, Taketo MM, Birchmeier W and Hartmann C: Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 8:727–738. 2005. View Article : Google Scholar : PubMed/NCBI
42	Xu C, Wang J, Zhu T, Shen Y, Tang X, Fang L and Xu Y: Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther. 11:247–254. 2016. View Article : Google Scholar : PubMed/NCBI
43	Day TF, Guo X, Garrett-Beal L and Yang Y: Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 8:739–750. 2005. View Article : Google Scholar : PubMed/NCBI
44	Leucht P, Jiang J, Cheng D, Liu B, Dhamdhere G, Fang MY, Monica SD, Urena JJ, Cole W, Smith LR, et al: Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals. J Bone Joint Surg Am. 95:1278–1288. 2013. View Article : Google Scholar : PubMed/NCBI
45	Duan P and Bonewald LF: The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int J Biochem Cell Biol. 77:23–29. 2016. View Article : Google Scholar : PubMed/NCBI
46	Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R and Alman BA: Beta-catenin signaling plays a disparate role in different phases of fracture repair: Implications for therapy to improve bone healing. PLoS Med. 4:e2492007. View Article : Google Scholar : PubMed/NCBI
47	Albers J, Keller J, Baranowsky A, Beil FT, Catala-Lehnen P, Schulze J, Amling M and Schinke T: Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol. 200:537–549. 2013. View Article : Google Scholar : PubMed/NCBI
48	Xu L, Cui WH, Zhou WC, Li DL, Li LC, Zhao P, Mo XT, Zhang Z and Gao J: Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation. J Cell Mol Med. 21:1545–1554. 2017. View Article : Google Scholar : PubMed/NCBI
49	Shi L, Wu YX, Yu JH, Chen X, Luo XJ and Yin YR: Research of the relationship between β-catenin and c-myc-mediated Wnt pathway and laterally spreading tumors occurrence. Eur Rev Med Pharmacol Sci. 21:252–257. 2017.PubMed/NCBI
50	Loveridge N, Farquharson C, Hesketh JE, Jakowlew SB, Whitehead CC and Thorp BH: The control of chondrocyte differentiation during endochondral bone growth in vivo: Changes in TGF-beta and the proto-oncogene c-myc. J Cell Sci. 105:949–956. 1993.PubMed/NCBI